Verve Therapeutics, Inc.

The current price of VERV is 6.64 USD — it has decreased by 0.30% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Verve Therapeutics, Inc. stocks are traded under the ticker VERV.

Verve Therapeutics, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.

VERV stock is 5.92% volatile and has beta coefficient of 4.97. Check out the list of the most volatile stocks — is Verve Therapeutics, Inc. there?

One year price forecast for Verve Therapeutics, Inc. has a max estimate of 55.00 USD and a min estimate of 15.00 USD.

VERV earnings for the last quarter are −0.72 USD per share, whereas the estimation was −0.90 USD resulting in a 20.42% surprise. The estimated earnings for the next quarter are −0.75 USD per share. See more details about Verve Therapeutics, Inc. earnings.

Verve Therapeutics, Inc. revenue for the last quarter amounts to ‪3.12 M‬ USD despite the estimated figure of ‪963.67 K‬ USD. In the next quarter revenue is expected to reach ‪3.77 M‬ USD.

Yes, you can track Verve Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

VERV net income for the last quarter is ‪−48.35 M‬ USD, while the quarter before that showed ‪−45.76 M‬ USD of net income which accounts for −5.67% change. Track more Verve Therapeutics, Inc. financial stats to get the full picture.

Today Verve Therapeutics, Inc. has the market capitalization of ‪523.14 M‬, it has increased by 0.96% over the last week.

No, VERV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, VERV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Verve Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

VERV reached its all-time high on Sep 7, 2021 with the price of 78.00 USD, and its all-time low was 7.36 USD and was reached on Apr 2, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 255.00 employees. See our rating of the largest employees — is Verve Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Verve Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Verve Therapeutics, Inc. stock shows the sell signal. See more of Verve Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Verve Therapeutics, Inc. future price: according to them, VERV price has a max estimate of 55.00 USD and a min estimate of 15.00 USD. Read a more detailed Verve Therapeutics, Inc. forecast: see what analysts think of Verve Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Verve Therapeutics, Inc. EBITDA is ‪−212.62 M‬ USD, and current EBITDA margin is ‪−1.85 K‬%. See more stats in Verve Therapeutics, Inc. financial statements.